Catalent and Parexel team up to offer clinical trial material supply services

By Natalie Morrison

- Last updated on GMT

Catalent and Parexel form alliance to provide clinical trial material supply services
Catalent and Parexel form alliance to provide clinical trial material supply services
Catalent and Parexel have teamed up to offer clinical trial material supply services.

Under the deal, Parexel will provide clinical logistics services such as global supply chain planning, forecasting and clinical trial material sourcing. Catalent will provide manufacturing, packaging, labelling and analytics services.

The firms say though they have been working together for years, there was demand for a more “formal”​ relationship which integrates the services and covers the full clinical trial life cycle.

“Customers that conduct global clinical trials view global scale and reach as a necessity, they are looking for fewer ‘preferred’ vendors with a broader set of capabilities, and real-time data and system connectivity between the sponsor and the supplier,”​ Catalent’s president of development and clinical services Scott Houlton told Outsourcing-Pharma.com.

Kurt Norris, corporate VP of clinical logistics for Parexel, added that in the current climate with many biopharma firms suffering the effects of patent expiry there is a need to improve research and development (R&D) productivity and efficiency to make up for revenue losses.

“The alliance directly addresses evolving market dynamics as well as customer needs,” ​he said.

What’s next?

The Parexel deal follows the acquisition of Aptuit​’s clinical trial supplies (CTS) business and is also part of "Catalent’s development and clinical services business growth strategy” ​according to Houlton.

He added that - as part of this growth effort - Catalent will seek more strategic partnerships, particularly in Asia where the firm will “continue to expand our development and clinical supply capabilities.”

As for Parexel, the growing business through the new alliance will be the key focus.

“We will be spending time with our clients discussing further the various benefits stemming from the alliance relative to our end-to-end clinical trial management supply chain solution as well as continuing to execute on those studies for which we are already extending various services,”​ said Norris.

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Ultra Low Temperature Packaging solutions

Ultra Low Temperature Packaging solutions

Content provided by Almac Group | 12-Feb-2024 | Case Study

Advanced Therapy Medicinal Products (ATMPs) offer ground-breaking opportunities for treating injuries and disease, in particular for cases of severe, untreatable...

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us

Products

View more

Webinars